362 related articles for article (PubMed ID: 16299310)
1. Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria.
Pal S; Peterson EM; de la Maza LM
Infect Immun; 2005 Dec; 73(12):8153-60. PubMed ID: 16299310
[TBL] [Abstract][Full Text] [Related]
2. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge.
Pal S; Theodor I; Peterson EM; de la Maza LM
Infect Immun; 2001 Oct; 69(10):6240-7. PubMed ID: 11553566
[TBL] [Abstract][Full Text] [Related]
3. A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge.
Pal S; Tatarenkova OV; de la Maza LM
Immunology; 2015 Nov; 146(3):432-43. PubMed ID: 26423798
[TBL] [Abstract][Full Text] [Related]
4. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge.
Pal S; Peterson EM; Rappuoli R; Ratti G; de la Maza LM
Vaccine; 2006 Feb; 24(6):766-75. PubMed ID: 16199110
[TBL] [Abstract][Full Text] [Related]
5. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge.
Pal S; Theodor I; Peterson EM; de la Maza LM
Infect Immun; 1997 Aug; 65(8):3361-9. PubMed ID: 9234798
[TBL] [Abstract][Full Text] [Related]
6. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challenge.
Pal S; Davis HL; Peterson EM; de la Maza LM
Infect Immun; 2002 Sep; 70(9):4812-7. PubMed ID: 12183524
[TBL] [Abstract][Full Text] [Related]
7. Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge.
Pal S; Luke CJ; Barbour AG; Peterson EM; de la Maza LM
Vaccine; 2003 Mar; 21(13-14):1455-65. PubMed ID: 12615442
[TBL] [Abstract][Full Text] [Related]
8. Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein.
Sun G; Pal S; Weiland J; Peterson EM; de la Maza LM
Vaccine; 2009 Aug; 27(36):5020-5. PubMed ID: 19446590
[TBL] [Abstract][Full Text] [Related]
9. A Recombinant Chlamydia trachomatis MOMP Vaccine Elicits Cross-serogroup Protection in Mice Against Vaginal Shedding and Infertility.
Tifrea DF; Pal S; de la Maza LM
J Infect Dis; 2020 Jan; 221(2):191-200. PubMed ID: 31504647
[TBL] [Abstract][Full Text] [Related]
10. Vaccination of newborn mice induces a strong protective immune response against respiratory and genital challenges with Chlamydia trachomatis.
Pal S; Peterson EM; de la Maza LM
Vaccine; 2005 Nov; 23(46-47):5351-8. PubMed ID: 16085340
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of the protective efficacy of a Chlamydia trachomatis recombinant vaccine by combining systemic and mucosal routes for immunization.
Ralli-Jain P; Tifrea D; Cheng C; Pal S; de la Maza LM
Vaccine; 2010 Nov; 28(48):7659-66. PubMed ID: 20875490
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with the recombinant major outer membrane protein elicits antibodies to the constant domains and induces cross-serovar protection against intranasal challenge with Chlamydia trachomatis.
Tifrea DF; Ralli-Jain P; Pal S; de la Maza LM
Infect Immun; 2013 May; 81(5):1741-50. PubMed ID: 23478318
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the nine polymorphic membrane proteins of Chlamydia trachomatis for their ability to induce protective immune responses in mice against a C. muridarum challenge.
Pal S; Favaroni A; Tifrea DF; Hanisch PT; Luczak SET; Hegemann JH; de la Maza LM
Vaccine; 2017 May; 35(19):2543-2549. PubMed ID: 28385608
[TBL] [Abstract][Full Text] [Related]
14. Intranasal immunization induces long-term protection in mice against a Chlamydia trachomatis genital challenge.
Pal S; Peterson EM; de la Maza LM
Infect Immun; 1996 Dec; 64(12):5341-8. PubMed ID: 8945586
[TBL] [Abstract][Full Text] [Related]
15. Induction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the nontoxic B subunit of cholera toxin.
Cheng C; Bettahi I; Cruz-Fisher MI; Pal S; Jain P; Jia Z; Holmgren J; Harandi AM; de la Maza LM
Vaccine; 2009 Oct; 27(44):6239-46. PubMed ID: 19686693
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine.
Ifere GO; He Q; Igietseme JU; Ananaba GA; Lyn D; Lubitz W; Kellar KL; Black CM; Eko FO
J Microbiol Immunol Infect; 2007 Jun; 40(3):188-200. PubMed ID: 17639158
[TBL] [Abstract][Full Text] [Related]
17. Induction of protection against vaginal shedding and infertility by a recombinant Chlamydia vaccine.
Carmichael JR; Pal S; Tifrea D; de la Maza LM
Vaccine; 2011 Jul; 29(32):5276-83. PubMed ID: 21609745
[TBL] [Abstract][Full Text] [Related]
18. Vaccination of mice with DNA plasmids coding for the Chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge.
Pal S; Barnhart KM; Wei Q; Abai AM; Peterson EM; de la Maza LM
Vaccine; 1999 Feb; 17(5):459-65. PubMed ID: 10073724
[TBL] [Abstract][Full Text] [Related]
19. Protection of pigs against Chlamydia trachomatis challenge by administration of a MOMP-based DNA vaccine in the vaginal mucosa.
Schautteet K; Stuyven E; Beeckman DS; Van Acker S; Carlon M; Chiers K; Cox E; Vanrompay D
Vaccine; 2011 Feb; 29(7):1399-407. PubMed ID: 21195805
[TBL] [Abstract][Full Text] [Related]
20. A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors.
Cheng C; Jain P; Bettahi I; Pal S; Tifrea D; de la Maza LM
Vaccine; 2011 Sep; 29(38):6641-9. PubMed ID: 21742006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
